Dianthus Therapeutics, Inc.

DNTH· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$96.81-4.26%

2026-09-18

Financials

Valuation Metrics

Dianthus Therapeutics, Inc.'s Market Cap is $5.42B. At end of 2025 it was $1.56B. Ranked #1266 of 3,121 in US market (top 41%), #427 of 1,463 on NASDAQ (top 29%), #75 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 28%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	$5.42B	US#1,266/3,121 Sec#75/266
Revenue	$2M	US#2,869/3,121 Sec#188/266
Net Income	$-30M	US—/3,121 Sec—/266
Total Assets	$1.21B	US#2,390/3,121 Sec#87/266
Net Assets	$1.17B	US#1,667/3,121 Sec#58/266
Value
P/B	4.62x	US#2,197/3,121 Sec#139/266
P/S	2659.63x	US#2,995/3,121 Sec#202/266
FCF Yield	-2.88%	US—/3,121 Sec—/266
Profitability
ROE	-2.55%	US#2,203/3,121 Sec#70/266
ROA	-2.47%	US#2,413/3,121 Sec#79/266
Op. Margin	-11441.39%	US#2,873/3,121 Sec#188/266
Revenue Growth	-60.77%	US#2,750/3,121 Sec#166/266
Financial Health
Debt Ratio	3.52%	US#28/3,121 Sec#7/266
Total Debt	$1M	US#2,979/3,121 Sec#242/266
FCF	$-156M	US#2,725/3,121 Sec#179/266
Cash	$111M	US#2,170/3,121 Sec#166/266
Current Ratio	26.10x	US#96/3,121 Sec#15/266
Performance
1Y Return	149.06%	US#99/3,121 Sec#41/266
1M Return	-14.85%	US#2,664/3,121 Sec#203/266
From 52W High	-17.87%	US#1,066/3,121 Sec#74/266
1Y MDD	-20.20%	US#731/3,121 Sec#27/266
Trading
Volume	2,337,635 shares	US#1,366/3,121 Sec#145/266
Trading Value	$232M	US#786/3,121 Sec#50/266
Per Share
EPS	$-0.53	US—/3,121 Sec—/266
BPS	$20.95	US#1,191/3,121 Sec#27/266